Literature DB >> 7270727

Treatment of spontaneous panic attacks with chlomipramine.

S Gloger, L Grunhaus, B Birmacher, T Troudart.   

Abstract

Recurrent spontaneous panic attacks are psychophysiological symptoms present in panic disorder and agoraphobia with panic attacks. Effective pharmacological treatment for panic attacks is essential to any treatment plan for these conditions. The authors administered chlomipramine to 20 patients who had panic disorder or agoraphobia with panic attacks, and after 8 weeks of treatment 75% of the patients with each diagnosis were asymptomatic. These results support the claim that chlomipramine is highly effective in preventing recurrence of panic attacks.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7270727     DOI: 10.1176/ajp.138.9.1215

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  11 in total

1.  The effects of repeated doses of clomipramine and alprazolam on physiological, psychomotor and cognitive functions in normal subjects.

Authors:  D Allen; H V Curran; M Lader
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Behavioral, biochemical, and blood pressure responses to alprazolam in healthy subjects: interactions with yohimbine.

Authors:  D S Charney; A Breier; P I Jatlow; G R Heninger
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects.

Authors:  D S Charney; S W Woods; W K Goodman; G R Heninger
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 4.  The utility of the panic disorder concept.

Authors:  D F Klein; H M Klein
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

Review 5.  Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder.

Authors:  D McTavish; P Benfield
Journal:  Drugs       Date:  1990-01       Impact factor: 9.546

6.  Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin.

Authors:  J A Den Boer; H G Westenberg
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

7.  Attenuation of antipredator defensive behavior in rats following chronic treatment with imipramine.

Authors:  R J Blanchard; J K Shepherd; R J Rodgers; L Magee; D C Blanchard
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 8.  Pharmacological challenge studies with acute psychosocial stress.

Authors:  Kathryne Van Hedger; Anya K Bershad; Harriet de Wit
Journal:  Psychoneuroendocrinology       Date:  2017-08-22       Impact factor: 4.905

9.  Reversible acute renal failure associated with clomipramine-induced interstitial nephritis.

Authors:  Akira Onishi; Hisashi Yamamoto; Tetsu Akimoto; Osamu Saito; Makoto Inoue; Yasuhiro Ando; Shigeaki Muto; Eiji Kusano
Journal:  Clin Exp Nephrol       Date:  2007-09-28       Impact factor: 2.801

Review 10.  Antidepressant drugs and the emergence of suicidal tendencies.

Authors:  M H Teicher; C A Glod; J O Cole
Journal:  Drug Saf       Date:  1993-03       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.